Reactome Pathway Database

About
Content
Docs
Tools
Community
Download

Schema > Disease > Entries

head and neck squamous cell carcinoma Show undefined attributes

created [InstanceEdit:1248676] Orlic-Milacic, Marija, 2011年04月12日

databaseName DOID

dbId 1248679

displayName head and neck squamous cell carcinoma

identifier 5520

name

head and neck squamous cell carcinoma

referenceDatabase [ReferenceDatabase:1247631] DOID

schemaClass Disease

synonym

carcinoma of the head and neck
squamous cell carcinoma of the head and neck

url https://www.ebi.ac.uk/ols/ontologies/doid/terms?obo_id=DOID:5520

Referrals

(disease)

[EntityWithAccessionedSequence:R-HSA-9632588] p16INK4A E88* [cytosol]
[EntityWithAccessionedSequence:R-HSA-9632585] p16INK4A W110* [cytosol]
[EntityWithAccessionedSequence:R-HSA-9632586] p16INK4A R80* [cytosol]
[EntityWithAccessionedSequence:R-HSA-9630916] p16INK4A P114L [cytosol]
[EntityWithAccessionedSequence:R-HSA-9632582] p16INK4A R58* [cytosol]
[EntityWithAccessionedSequence:R-HSA-9632483] p16INK4A D84N [cytosol]
[EntityWithAccessionedSequence:R-HSA-9632478] p16INK4A D84Y [cytosol]
[EntityWithAccessionedSequence:R-HSA-9648383] p16INK4A S12* [cytosol]
[EntityWithAccessionedSequence:R-HSA-9648652] p16INK4A G23fs*3 [cytosol]
[EntityWithAccessionedSequence:R-HSA-9648397] p16INK4A E69* [cytosol]
[EntityWithAccessionedSequence:R-HSA-9648393] p16INK4A E33* [cytosol]
[EntityWithAccessionedSequence:R-HSA-9632587] p16INK4A E120* [cytosol]
[EntityWithAccessionedSequence:R-HSA-9648390] p16INK4A E119* [cytosol]
[EntityWithAccessionedSequence:R-HSA-9648387] p16INK4A E27* [cytosol]
[EntityWithAccessionedSequence:R-HSA-9724561] PALB2 G1043C [nucleoplasm]
[EntityWithAccessionedSequence:R-HSA-9703800] BRCA1 V83Cfs*2 [nucleoplasm]
[EntityWithAccessionedSequence:R-HSA-9702769] BRCA1 Y655* [nucleoplasm]
[EntityWithAccessionedSequence:R-HSA-9726075] TP53 L344P [nucleoplasm]
[Pathway:R-HSA-9710421] Defective pyroptosis
[FailedReaction:R-HSA-9710468] GSDME variant does not bind PIPs
[CandidateSet:R-HSA-9710467] GSDME variant [cytosol]
[EntityWithAccessionedSequence:R-HSA-9710403] GSDME(1-270) E177V [cytosol]
[EntityWithAccessionedSequence:R-HSA-9662288] RB1 K745* [cytosol]
[EntityWithAccessionedSequence:R-HSA-9661919] RB1 E275* [cytosol]
[EntityWithAccessionedSequence:R-HSA-9688141] RB1 L158Mfs*19 [cytosol]
[EntityWithAccessionedSequence:R-HSA-9660640] RB1 R251* [cytosol]
[Complex:R-HSA-190228] FGFR1b homodimer [plasma membrane]
[EntityWithAccessionedSequence:R-HSA-9656564] HRAS G12D [plasma membrane]
[EntityWithAccessionedSequence:R-HSA-9656572] HRAS G13D [plasma membrane]
[EntityWithAccessionedSequence:R-HSA-9656579] HRAS G13V [plasma membrane]
[EntityWithAccessionedSequence:R-HSA-9651177] KRAS K147N [plasma membrane]
[EntityWithAccessionedSequence:R-HSA-9652785] p-T185,Y187 MAPK1 D321N [cytosol]
[EntityWithAccessionedSequence:R-HSA-9652806] p-T185,Y187 MAPK1 P58L [cytosol]
[EntityWithAccessionedSequence:R-HSA-9652175] p-T185,Y187 MAPK1 E322K [cytosol]
[DefinedSet:R-HSA-1982053] Overexpressed FGFR1 homodimers [plasma membrane]
[EntityWithAccessionedSequence:R-HSA-2032969] p-6Y-FGFR3b G697C [plasma membrane]
[Complex:R-HSA-2033340] Activated FGFR3b G967C [plasma membrane]
[EntityWithAccessionedSequence:R-HSA-8853147] p-4Y-FGFR3(23-760)-TACC3(612-838) fusion [plasma membrane]
[Complex:R-HSA-8853208] p-4Y FGFR3(23-760)-TACC3(612-838) dimer [plasma membrane]
[EntityWithAccessionedSequence:R-HSA-1226874] p-6Y-FGFR3b S249C mutant [plasma membrane]
[Complex:R-HSA-1226875] Activated FGFR3b S249C mutant [plasma membrane]
[EntityWithAccessionedSequence:R-HSA-1614419] FGFR3 R248C [plasma membrane]
[EntityWithAccessionedSequence:R-HSA-1226109] FGFR3b S249C [plasma membrane]
[EntityWithAccessionedSequence:R-HSA-2018743] FGFR3b G697C [plasma membrane]
[Complex:R-HSA-2033342] FGFR3b G697C mutant dimer [plasma membrane]
[EntityWithAccessionedSequence:R-HSA-8853144] FGFR3(23-760)-TACC3(612-838) fusion [plasma membrane]
[Complex:R-HSA-8853196] FGFR3(23-760)-TACC3(612-838) dimer [plasma membrane]
[EntityWithAccessionedSequence:R-HSA-9669545] KIT T670I [plasma membrane]
[EntityWithAccessionedSequence:R-HSA-9699449] p-6Y FLT3 Y842H [plasma membrane]
[EntityWithAccessionedSequence:R-HSA-9699443] FLT3 Y842H [plasma membrane]
[EntityWithAccessionedSequence:R-HSA-9659326] PTEN Q245* [cytosol]
[EntityWithAccessionedSequence:R-HSA-9659307] PTEN Q214* [cytosol]
[EntityWithAccessionedSequence:R-HSA-9659312] PTEN Q171* [cytosol]
[EntityWithAccessionedSequence:R-HSA-9659305] PTEN Q17* [cytosol]
[EntityWithAccessionedSequence:R-HSA-1500709] PIK3CA E545G [cytosol]
[EntityWithAccessionedSequence:R-HSA-2362362] PIK3CA E545Q [cytosol]
[EntityWithAccessionedSequence:R-HSA-1500706] PIK3CA E545K [cytosol]
[EntityWithAccessionedSequence:R-HSA-1500701] PIK3CA E542K [cytosol]
[EntityWithAccessionedSequence:R-HSA-2395932] PIK3CA M1043V [cytosol]
[EntityWithAccessionedSequence:R-HSA-1500716] PIK3CA H1047R [cytosol]
[EntityWithAccessionedSequence:R-HSA-9675175] SMAD4 Q245* [cytosol]
[EntityWithAccessionedSequence:R-HSA-9675173] SMAD4 Q256* [cytosol]
[EntityWithAccessionedSequence:R-HSA-9675625] SMAD4 S144* [cytosol]
[EntityWithAccessionedSequence:R-HSA-3310984] SMAD4 R361H [cytosol]
[EntityWithAccessionedSequence:R-HSA-3308499] SMAD3 S425C [cytosol]
[EntityWithAccessionedSequence:R-HSA-9668765] SMAD3 Q316* [cytosol]
[EntityWithAccessionedSequence:R-HSA-1228031] EGFR E746_T751delinsA [plasma membrane]
[EntityWithAccessionedSequence:R-HSA-1228034] EGFR L747_A750delinsP [plasma membrane]
[EntityWithAccessionedSequence:R-HSA-1228010] EGFR L747_P753delinsS [plasma membrane]
[EntityWithAccessionedSequence:R-HSA-1181211] EGFR E746_A750del [plasma membrane]
[ProteinDrug:R-ALL-1248673] Cetuximab [extracellular region]
[Complex:R-HSA-1248675] EGFR:Cetuximab [plasma membrane]
[Reaction:R-HSA-1248677] Inactivation of over-expressed wild type EGFR by Cetuximab recombinant antibody
[EntityWithAccessionedSequence:R-HSA-9660669] RB1 Q344* [cytosol]

Cite Us!